{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T04:03:35Z","timestamp":1751515415191,"version":"3.41.0"},"posted":{"date-parts":[[2024,8,12]]},"group-title":"In Review","reference-count":47,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:00:00Z","timestamp":1723420800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,7,22]]},"abstract":"<title>Abstract<\/title>\n        <p>Previous studies have shown that glial and neuronal changes may trigger synaptic dysfunction in Alzheimer\u2019s disease(AD). However, the link between glial and neuronal markers and synaptic abnormalities in the living brain is poorly understood. Here, we investigated the association between biomarkers of astrocyte and microglial reactivity and synaptic dysfunction in 478 individuals across the aging and AD spectrum from two cohorts with available CSF measures of amyloid-\u03b2(A\u03b2), phosphorylated tau(pTau181), astrocyte reactivity(GFAP), microglial activation(sTREM2), and synaptic biomarkers(GAP43 and neurogranin). Elevated CSF GFAP levels were linked to presynaptic and postsynaptic dysfunction, regardless of cognitive status or A\u03b2 presence. CSF sTREM2 levels were associated with presynaptic biomarkers in cognitively unimpaired and impaired A\u03b2\u2009+\u2009individuals and postsynaptic biomarkers in cognitively impaired A\u03b2\u2009+\u2009individuals. Notably, CSF pTau181 levels mediated all associations between GFAP or sTREM2 levels and synaptic dysfunction biomarkers. These results suggest that neuronal-related synaptic biomarkers could be used in clinical trials targeting glial reactivity in AD.<\/p>","DOI":"10.21203\/rs.3.rs-4782732\/v1","type":"posted-content","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T03:18:46Z","timestamp":1723432726000},"source":"Crossref","is-referenced-by-count":0,"title":["Glial reactivity is linked to synaptic dysfunction across the aging and Alzheimer\u2019s disease spectrum"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9057-8014","authenticated-orcid":false,"given":"Tharick","family":"Pascoal","sequence":"first","affiliation":[{"name":"University of Pittsburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francieli","family":"Rohden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2134-9829","authenticated-orcid":false,"given":"Pamela","family":"Ferreira","sequence":"additional","affiliation":[{"name":"University of Pittsburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2212-3373","authenticated-orcid":false,"given":"Bruna","family":"Bellaver","sequence":"additional","affiliation":[{"name":"University of Pittsburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Pedro","family":"Ferrari-Souza","sequence":"additional","affiliation":[{"name":"University of Pittsburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiano","family":"Aguzzoli","sequence":"additional","affiliation":[{"name":"University of Pittsburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2338-4495","authenticated-orcid":false,"given":"Carolina","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Abbas","sequence":"additional","affiliation":[{"name":"University of Pittsburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussein","family":"Zalzale","sequence":"additional","affiliation":[{"name":"University of Pittsburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2023-6569","authenticated-orcid":false,"given":"Guilherme","family":"Povala","sequence":"additional","affiliation":[{"name":"University of Pittsburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Firoza","family":"Lussier","sequence":"additional","affiliation":[{"name":"University of Pittsburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Leffa","sequence":"additional","affiliation":[{"name":"University of Pittsburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilherme","family":"Bauer-Negrini","sequence":"additional","affiliation":[{"name":"University of Pittsburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nesrine","family":"Rahmouni","sequence":"additional","affiliation":[{"name":"McGill University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"Tissot","sequence":"additional","affiliation":[{"name":"McGill University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph Therriault","family":"Therriault","sequence":"additional","affiliation":[{"name":"McGill University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stijn","family":"Servaes","sequence":"additional","affiliation":[{"name":"McGill University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenna","family":"Stevenson","sequence":"additional","affiliation":[{"name":"McGill University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Benedet","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, M\u00f6lndal, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Ashton","sequence":"additional","affiliation":[{"name":"University of Gothenburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Karikari","sequence":"additional","affiliation":[{"name":"University of Pittsburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Tudorascu","sequence":"additional","affiliation":[{"name":"University of Pittsburgh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3930-4354","authenticated-orcid":false,"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[{"name":"University of Gothenburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1890-4193","authenticated-orcid":false,"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[{"name":"University of Gothenburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Zimmer","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diogo","family":"Souza","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9116-1376","authenticated-orcid":false,"given":"Pedro","family":"Rosa-Neto","sequence":"additional","affiliation":[{"name":"McGill Univeristy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.molmed.2022.05.008","article-title":"Staging of Alzheimer\u2019s disease: past, present, and future perspectives","volume":"28","author":"Therriault J","year":"2022","unstructured":"Therriault J et al (2022) Staging of Alzheimer\u2019s disease: past, present, and future perspectives. Trends Mol Med 28:726\u2013741","journal-title":"Trends Mol Med"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman DS","year":"2021","unstructured":"Knopman DS et al (2021) Alzheimer disease. Nat Rev Dis Primer 7","journal-title":"Nat Rev Dis Primer"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2024.100721","article-title":"Alzheimer\u2019s Disease Biomarker Analysis Using Targeted Mass Spectrometry","volume":"23","author":"Gobom J","year":"2024","unstructured":"Gobom J, Brinkmalm A, Brinkmalm G, Blennow K, Zetterberg H (2024) Alzheimer\u2019s Disease Biomarker Analysis Using Targeted Mass Spectrometry. Mol Cell Proteom 23","journal-title":"Mol Cell Proteom"},{"key":"ref4","article-title":"Insights into early pathogenesis of sporadic Alzheimer\u2019s disease: role of oxidative stress and loss of synaptic proteins","volume":"17","author":"Ansari MA","year":"2023","unstructured":"Ansari MA, Rao MS, Al-Jarallah A (2023) Insights into early pathogenesis of sporadic Alzheimer\u2019s disease: role of oxidative stress and loss of synaptic proteins. Front Neurosci 17","journal-title":"Front Neurosci"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.tins.2020.01.003","article-title":"Astrocytes and Microglia: In Sickness and in Health","volume":"43","author":"Vainchtein ID","year":"2020","unstructured":"Vainchtein ID, Molofsky AV (2020) Astrocytes and Microglia: In Sickness and in Health. Trends Neurosci 43:144\u2013154","journal-title":"Trends Neurosci"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00418","article-title":"Microglia P2Y13 receptors prevent astrocyte proliferation mediated by P2Y1 receptors","volume":"9","author":"Quintas C","year":"2018","unstructured":"Quintas C, Vale N, Gon\u00e7alves J, Queiroz G (2018) Microglia P2Y13 receptors prevent astrocyte proliferation mediated by P2Y1 receptors. Front Pharmacol 9","journal-title":"Front Pharmacol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1007\/s11064-022-03699-6","article-title":"A\u00df Pathology and Neuron\u2013Glia Interactions: A Synaptocentric View","volume":"48","author":"Huffels CFM","year":"2023","unstructured":"Huffels CFM, Middeldorp J, Hol EM (2023) A\u00df Pathology and Neuron\u2013Glia Interactions: A Synaptocentric View. Neurochem Res 48:1026\u20131046","journal-title":"Neurochem Res"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105630","article-title":"Soluble TREM2: Innocent bystander or active player in neurological diseases?","volume":"165","author":"Filipello F","year":"2022","unstructured":"Filipello F et al (2022) Soluble TREM2: Innocent bystander or active player in neurological diseases? Neurobiol Dis 165","journal-title":"Neurobiol Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.molmed.2018.11.006","article-title":"Astrocyte Biomarkers in Alzheimer\u2019s Disease","volume":"25","author":"Carter SF","year":"2019","unstructured":"Carter SF et al (2019) Astrocyte Biomarkers in Alzheimer\u2019s Disease. Trends Mol Med 25:77\u201395","journal-title":"Trends Mol Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","article-title":"Reactive astrocyte nomenclature, definitions, and future directions","volume":"24","author":"Escartin C","year":"2021","unstructured":"Escartin C et al (2021) Reactive astrocyte nomenclature, definitions, and future directions. Nat Neurosci 24:312\u2013325","journal-title":"Nat Neurosci"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.immuni.2021.01.013","article-title":"Astrocyte-immune cell interactions in physiology and pathology","volume":"54","author":"Han RT","year":"2021","unstructured":"Han RT, Kim RD, Molofsky AV, Liddelow SA (2021) Astrocyte-immune cell interactions in physiology and pathology. Immunity 54:211\u2013224","journal-title":"Immunity"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.3390\/cells12151942","article-title":"Microglia\u2013Astrocyte Interaction in Neural Development and Neural Pathogenesis","volume":"12","author":"Sun M","year":"2023","unstructured":"Sun M et al (2023) Microglia\u2013Astrocyte Interaction in Neural Development and Neural Pathogenesis. Cells 12:1942","journal-title":"Cells"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02380-x","article-title":"Astrocyte reactivity influences amyloid-\u03b2 effects on tau pathology in preclinical Alzheimer\u2019s disease","author":"Bellaver B","year":"2023","unstructured":"Bellaver B et al (2023) Astrocyte reactivity influences amyloid-\u03b2 effects on tau pathology in preclinical Alzheimer\u2019s disease. Nat Med. 10.1038\/s41591-023-02380-x","journal-title":"Nat Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1016\/S2666-7568(20)30061-1","article-title":"Serum markers glial fibrillary acidic protein and neurofilament light for prognosis and monitoring in cognitively normal older people: a prospective memory clinic-based cohort study","volume":"2","author":"Verberk IMW","year":"2021","unstructured":"Verberk IMW et al (2021) Serum markers glial fibrillary acidic protein and neurofilament light for prognosis and monitoring in cognitively normal older people: a prospective memory clinic-based cohort study. Lancet Healthy Longev 2:e87\u2013e95","journal-title":"Lancet Healthy Longev"},{"year":"2023","author":"Ferrari-Souza JP","key":"ref15","unstructured":"Ferrari-Souza JP et al (2023) APOE\u03b54 Associates with Microglial Activation Independently of A\u03b2 Plaques and Tau Tangles"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/s41591-021-01456-w","article-title":"Microglial activation and tau propagate jointly across Braak stages","volume":"27","author":"Pascoal TA","year":"2021","unstructured":"Pascoal TA et al (2021) Microglial activation and tau propagate jointly across Braak stages. Nat Med 27:1592\u20131599","journal-title":"Nat Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1038\/s41380-022-01565-z","article-title":"The synapse as a treatment avenue for Alzheimer\u2019s Disease","volume":"27","author":"Peng L","year":"2022","unstructured":"Peng L, Bestard-Lorigados I, Song W (2022) The synapse as a treatment avenue for Alzheimer\u2019s Disease. Mol Psychiatry 27:2940\u20132949","journal-title":"Mol Psychiatry"},{"key":"ref18","doi-asserted-by":"crossref","DOI":"10.1016\/j.conb.2023.102706","article-title":"Mechanical transmission at spine synapses: Short-term potentiation and working memory","volume":"80","author":"Kasai H","year":"2023","unstructured":"Kasai H, Ucar H, Morimoto Y, Eto F, Okazaki H (2023) Mechanical transmission at spine synapses: Short-term potentiation and working memory. Curr Opin Neurobiol 80","journal-title":"Curr Opin Neurobiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/glia.24450","article-title":"Increased membrane\u2009<\u2009scp\u2009>\u2009Ca 2+ \u2009permeability drives astrocytic\u2009<\u2009scp\u2009>\u2009Ca 2+ \u2009dynamics during neuronal stimulation at excitatory synapses","author":"Hjukse JB","year":"2023","unstructured":"Hjukse JB et al (2023) Increased membrane\u2009<\u2009scp\u2009>\u2009Ca 2+ \u2009permeability drives astrocytic\u2009<\u2009scp\u2009>\u2009Ca 2+ \u2009dynamics during neuronal stimulation at excitatory synapses. Glia. 10.1002\/glia.24450","journal-title":"Glia"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.3233\/JAD-215456","article-title":"The Trajectory of Cerebrospinal Fluid Growth-Associated Protein 43 in the Alzheimer\u2019s Disease Continuum: A Longitudinal Study","volume":"85","author":"Zhang H","year":"2022","unstructured":"Zhang H, Lyu D, Jia J (2022) The Trajectory of Cerebrospinal Fluid Growth-Associated Protein 43 in the Alzheimer\u2019s Disease Continuum: A Longitudinal Study. J Alzheimers Dis 85:1441\u20131452","journal-title":"J Alzheimers Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"E275","DOI":"10.1212\/WNL.0000000000201417","article-title":"Association of CSF GAP-43 With the Rate of Cognitive Decline and Progression to Dementia in Amyloid-Positive Individuals","volume":"100","author":"\u00d6hrfelt A","year":"2023","unstructured":"\u00d6hrfelt A et al (2023) Association of CSF GAP-43 With the Rate of Cognitive Decline and Progression to Dementia in Amyloid-Positive Individuals. Neurology 100:E275\u2013E285","journal-title":"Neurology"},{"key":"ref22","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.105991","article-title":"Neurogranin in Alzheimer\u2019s disease and ageing: A human post-mortem study","volume":"177","author":"Saunders T","year":"2023","unstructured":"Saunders T et al (2023) Neurogranin in Alzheimer\u2019s disease and ageing: A human post-mortem study. Neurobiol Dis 177","journal-title":"Neurobiol Dis"},{"key":"ref23","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics11122339","article-title":"Neurogranin as a reliable biomarker for synaptic dysfunction in alzheimer\u2019s disease","volume":"11","author":"Agnello L","year":"2021","unstructured":"Agnello L et al (2021) Neurogranin as a reliable biomarker for synaptic dysfunction in alzheimer\u2019s disease. Diagnostics 11","journal-title":"Diagnostics"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"E2065","DOI":"10.1212\/WNL.0000000000012853","article-title":"CSF Synaptic Biomarkers in the Preclinical Stage of Alzheimer Disease and Their Association With MRI and PET A Cross-sectional Study","volume":"97","author":"Mil\u00e0-Alom\u00e0 M","year":"2021","unstructured":"Mil\u00e0-Alom\u00e0 M et al (2021) CSF Synaptic Biomarkers in the Preclinical Stage of Alzheimer Disease and Their Association With MRI and PET A Cross-sectional Study. Neurology 97:E2065\u2013E2078","journal-title":"Neurology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1038\/s41467-021-25344-6","article-title":"Improved modeling of human AD with an automated culturing platform for iPSC neurons, astrocytes and microglia","volume":"12","author":"Bassil R","year":"2021","unstructured":"Bassil R et al (2021) Improved modeling of human AD with an automated culturing platform for iPSC neurons, astrocytes and microglia. Nat Commun 12:5220","journal-title":"Nat Commun"},{"key":"ref26","article-title":"Soluble TREM2 ameliorates tau phosphorylation and cognitive deficits through activating transgelin-2 in Alzheimer\u2019s disease","volume":"14","author":"Zhang X","year":"2023","unstructured":"Zhang X et al (2023) Soluble TREM2 ameliorates tau phosphorylation and cognitive deficits through activating transgelin-2 in Alzheimer\u2019s disease. Nat Commun 14","journal-title":"Nat Commun"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.1038\/s41380-020-0688-6","article-title":"APOE\u03b54 potentiates the relationship between amyloid-\u03b2 and tau pathologies","volume":"26","author":"Therriault J","year":"2021","unstructured":"Therriault J et al (2021) APOE\u03b54 potentiates the relationship between amyloid-\u03b2 and tau pathologies. Mol Psychiatry 26:5977\u20135988","journal-title":"Mol Psychiatry"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1001\/jamaneurol.2021.3671","article-title":"Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum","volume":"78","author":"Benedet AL","year":"2021","unstructured":"Benedet AL et al (2021) Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum. JAMA Neurol 78:1471","journal-title":"JAMA Neurol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.jalz.2018.01.010","article-title":"CSF biomarkers of Alzheimer\u2019s disease concord with amyloid-\u03b2 PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts","volume":"14","author":"Hansson O","year":"2018","unstructured":"Hansson O et al (2018) CSF biomarkers of Alzheimer\u2019s disease concord with amyloid-\u03b2 PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts. Alzheimers Dement 14:1470\u20131481","journal-title":"Alzheimers Dement"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.exger.2019.04.003","article-title":"Exercise as a potential modulator of inflammation in patients with Alzheimer\u2019s disease measured in cerebrospinal fluid and plasma","volume":"121","author":"Jensen CS","year":"2019","unstructured":"Jensen CS et al (2019) Exercise as a potential modulator of inflammation in patients with Alzheimer\u2019s disease measured in cerebrospinal fluid and plasma. Exp Gerontol 121:91\u201398","journal-title":"Exp Gerontol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40035-024-00420-1","article-title":"The relation of synaptic biomarkers with A\u03b2, tau, glial activation, and neurodegeneration in Alzheimer\u2019s disease","volume":"13","author":"Wang Y-T","year":"2024","unstructured":"Wang Y-T et al (2024) The relation of synaptic biomarkers with A\u03b2, tau, glial activation, and neurodegeneration in Alzheimer\u2019s disease. Transl Neurodegener 13:27","journal-title":"Transl Neurodegener"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s40520-018-0948-3","article-title":"Association of cerebrospinal fluid Neurogranin with Alzheimer\u2019s disease","volume":"31","author":"Wang L","year":"2019","unstructured":"for the Alzheimer\u2019s Disease Neuroimaging Initiative &, Wang L (2019) Association of cerebrospinal fluid Neurogranin with Alzheimer\u2019s disease. Aging Clin Exp Res 31:185\u2013191","journal-title":"Aging Clin Exp Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jalz.2018.08.006","article-title":"Elevated CSF GAP-43 is Alzheimer\u2019s disease specific and associated with tau and amyloid pathology","volume":"15","author":"Sandelius \u00c5","year":"2019","unstructured":"Sandelius \u00c5 et al (2019) Elevated CSF GAP-43 is Alzheimer\u2019s disease specific and associated with tau and amyloid pathology. Alzheimers Dement 15:55\u201364","journal-title":"Alzheimers Dement"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ibneur.2022.12.003","article-title":"Neurodegeneration and inflammation crosstalk: Therapeutic targets and perspectives","volume":"14","author":"Mohamed W","year":"2023","unstructured":"Mohamed W, Kumar J, Alghamdi BS, Soliman A-H, Toshihide Y (2023) Neurodegeneration and inflammation crosstalk: Therapeutic targets and perspectives. IBRO Neurosci Rep 14:95\u2013110","journal-title":"IBRO Neurosci Rep"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e200052","DOI":"10.1212\/NXI.0000000000200052","article-title":"Serum GFAP and NfL Levels Differentiate Subsequent Progression and Disease Activity in Patients With Progressive Multiple Sclerosis","volume":"10","author":"Barro C","year":"2023","unstructured":"Barro C et al (2023) Serum GFAP and NfL Levels Differentiate Subsequent Progression and Disease Activity in Patients With Progressive Multiple Sclerosis. Neurol Neuroimmunol Neuroinflammation 10:e200052","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"year":"2018","author":"Clarke LE","key":"ref36","unstructured":"Clarke LE et al (2018) Normal aging induces A1-like astrocyte reactivity. Proc. Natl. Acad. Sci. U. S. A. 115, E1896\u2013E1905"},{"key":"ref37","article-title":"Cross-sectional and longitudinal evaluation of plasma glial fibrillary acidic protein to detect and predict clinical syndromes of Alzheimer\u2019s disease","volume":"15","author":"Ally M","year":"2023","unstructured":"Ally M et al (2023) Cross-sectional and longitudinal evaluation of plasma glial fibrillary acidic protein to detect and predict clinical syndromes of Alzheimer\u2019s disease. Alzheimers Dement Diagn Assess Dis Monit 15","journal-title":"Alzheimers Dement Diagn Assess Dis Monit"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41531-023-00447-7","article-title":"Plasma GFAP in Parkinson\u2019s disease with cognitive impairment and its potential to predict conversion to dementia","volume":"9","author":"Tang Y","year":"2023","unstructured":"Tang Y et al (2023) Plasma GFAP in Parkinson\u2019s disease with cognitive impairment and its potential to predict conversion to dementia. Npj Park Dis 9:23","journal-title":"Npj Park Dis"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1089\/neu.2013.2883","article-title":"GFAP-BDP as an Acute Diagnostic Marker in Traumatic Brain Injury: Results from the Prospective Transforming Research and Clinical Knowledge in Traumatic Brain Injury Study","volume":"30","author":"Okonkwo DO","year":"2013","unstructured":"Okonkwo DO et al (2013) GFAP-BDP as an Acute Diagnostic Marker in Traumatic Brain Injury: Results from the Prospective Transforming Research and Clinical Knowledge in Traumatic Brain Injury Study. J Neurotrauma 30:1490\u20131497","journal-title":"J Neurotrauma"},{"key":"ref40","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.899251","article-title":"The Role of Astrocytes in Synapse Loss in Alzheimer\u2019s Disease: A Systematic Review","volume":"16","author":"Hulshof LA","year":"2022","unstructured":"Hulshof LA, van Nuijs D, Hol EM, Middeldorp J (2022) The Role of Astrocytes in Synapse Loss in Alzheimer\u2019s Disease: A Systematic Review. Front Cell Neurosci 16","journal-title":"Front Cell Neurosci"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1093\/brain\/awac285","article-title":"Precuneus magnetic stimulation for Alzheimer\u2019s disease: a randomized, sham-controlled trial","volume":"145","author":"Koch G","year":"2022","unstructured":"Koch G et al (2022) Precuneus magnetic stimulation for Alzheimer\u2019s disease: a randomized, sham-controlled trial. Brain 145:3776\u20133786","journal-title":"Brain"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/brain\/awab294","article-title":"Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer\u2019s disease","volume":"145","author":"Strom A","year":"2022","unstructured":"Strom A et al (2022) Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer\u2019s disease. Brain 145:713\u2013728","journal-title":"Brain"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41582-022-00749-z","article-title":"Spires-Jones, T. L. Synaptic degeneration in Alzheimer disease","volume":"19","author":"Tzioras M","year":"2023","unstructured":"Tzioras M, McGeachan RI, Durrant CS (2023) Spires-Jones, T. L. Synaptic degeneration in Alzheimer disease. Nat Rev Neurol 19:19\u201338","journal-title":"Nat Rev Neurol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/bkcs.12792","article-title":"Insights to develop tau-directed therapeutics to protect the synaptic integrity for tauopathies","volume":"45","author":"Cha E","year":"2024","unstructured":"Cha E, Kim HJ, Lim SM (2024) Insights to develop tau-directed therapeutics to protect the synaptic integrity for tauopathies. Bull Korean Chem Soc 45:45\u201354","journal-title":"Bull Korean Chem Soc"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00401-022-02526-0","article-title":"Functional excitatory to inhibitory synaptic imbalance and loss of cognitive performance in people with Alzheimer\u2019s disease neuropathologic change","volume":"145","author":"Scaduto P","year":"2023","unstructured":"Scaduto P et al (2023) Functional excitatory to inhibitory synaptic imbalance and loss of cognitive performance in people with Alzheimer\u2019s disease neuropathologic change. Acta Neuropathol (Berl) 145:303\u2013324","journal-title":"Acta Neuropathol (Berl)"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"e16987","DOI":"10.15252\/emmm.202216987","article-title":"sTREM2 is associated with amyloid-related p\u2010tau increases and glucose hypermetabolism in Alzheimer\u2019s disease","volume":"15","author":"Biel D","year":"2023","unstructured":"Biel D et al (2023) sTREM2 is associated with amyloid-related p\u2010tau increases and glucose hypermetabolism in Alzheimer\u2019s disease. EMBO Mol Med 15:e16987","journal-title":"EMBO Mol Med"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/alz.12131","article-title":"Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer\u2019s continuum","volume":"16","author":"Mil\u00e0-Alom\u00e0 M","year":"2020","unstructured":"Mil\u00e0-Alom\u00e0 M et al (2020) Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer\u2019s continuum. Alzheimers Dement 16:1358\u20131371","journal-title":"Alzheimers Dement"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4782732\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4782732\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T07:16:00Z","timestamp":1751440560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4782732\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,12]]},"references-count":47,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-4782732\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1038\/s41467-025-60806-1","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,8,12]]},"subtype":"preprint"}}